ES8605375A1 - Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias. - Google Patents

Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.

Info

Publication number
ES8605375A1
ES8605375A1 ES540375A ES540375A ES8605375A1 ES 8605375 A1 ES8605375 A1 ES 8605375A1 ES 540375 A ES540375 A ES 540375A ES 540375 A ES540375 A ES 540375A ES 8605375 A1 ES8605375 A1 ES 8605375A1
Authority
ES
Spain
Prior art keywords
bacteria
compsn
esp
nontoxic
bacterial preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540375A
Other languages
English (en)
Other versions
ES540375A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmos Yhtyma Oy
Original Assignee
Farmos Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Yhtyma Oy filed Critical Farmos Yhtyma Oy
Publication of ES8605375A1 publication Critical patent/ES8605375A1/es
Publication of ES540375A0 publication Critical patent/ES540375A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA COMPOSICION VETERINARIA A BASE DE BACTERIAS ANAEROBIAS Y UN AGENTE CONSERVADOR DE LA EFICACIA DE DICHAS BACTERIAS. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE DILUYE CON AGUA UNA MASA DE CELULAS BACTERIANAS ANAEROBIAS CONGELADAS O LIOFILIZADAS; SEGUNDA, SE AÑADE A DICHA SOLUCION DILUIDA CISTEINA QUE ACTUA COMO AGENTE DE CONSERVACION DE LA EFICACIA DE DICHAS BACTERIAS, REDUCIENDO EL EFECTO TOXICO DEL OXIGENO DISUELTO EN EL AGUA; Y POR ULTIMO, OPCIONALMENTE SE AJUSTA EL PH DE LA SOLUCION HASTA UN VALOR PROXIMO A LA NEUTRALIDAD, MEDIANTE LA ADICION DE COMPUESTOS CON UN EFECTO TAMPON ADECUADO. DE APLICACION EN EL TRATAMIENTO DE LA FLORA BACTERIANA.
ES540375A 1984-03-01 1985-02-13 Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias. Expired ES8605375A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI840816A FI840816A0 (fi) 1984-03-01 1984-03-01 Bakteriepreparat

Publications (2)

Publication Number Publication Date
ES8605375A1 true ES8605375A1 (es) 1986-03-16
ES540375A0 ES540375A0 (es) 1986-03-16

Family

ID=8518638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540375A Expired ES8605375A1 (es) 1984-03-01 1985-02-13 Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.

Country Status (10)

Country Link
US (1) US4657762A (es)
EP (1) EP0154478A3 (es)
JP (1) JPH0759516B2 (es)
AU (1) AU581198B2 (es)
CA (1) CA1236400A (es)
DK (1) DK70385A (es)
ES (1) ES8605375A1 (es)
FI (1) FI840816A0 (es)
NO (1) NO165744C (es)
ZA (1) ZA85324B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
DE68928665T2 (de) * 1988-08-02 1998-11-12 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
US5206015A (en) * 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
GB2233343B (en) * 1989-06-30 1993-07-07 Farmos Oy A bacterial preparation for use in poultry
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5302388A (en) * 1991-11-13 1994-04-12 Wisconsin Alumni Research Foundation Control of campylobacter jejuni colonization
CN1076586C (zh) * 1993-03-16 2001-12-26 美国政府农业部 粘膜的竞争性排斥菌群
AU3692395A (en) * 1994-07-29 1996-03-04 United States Of America, As Represented By The Secretary Of Agriculture, The Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry
US5722342A (en) * 1996-06-28 1998-03-03 Us Agriculure Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians
US5807546A (en) 1996-10-11 1998-09-15 The United States Of America As Represented By The Secretary Of Agriculture Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
NZ561654A (en) 2005-03-18 2010-07-30 Us Agriculture Bacteriocins from Lactobacillis acidophilus NRRL B-30510
EP2351494A1 (en) 2005-03-18 2011-08-03 The United States of America as represented by the secretary of Agriculture Bacteriocins and novel bacterial strains
BR112013001107B1 (pt) 2010-07-16 2022-01-25 The Board Of Trustees Of The University Of Arkansas Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais
EP3701958A1 (en) 2010-08-04 2020-09-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
PL2683390T3 (pl) 2011-03-09 2018-04-30 Regents Of The University Of Minnesota Kompozycje i sposoby przeszczepiania mikrobioty okrężnicy
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
US9393275B2 (en) 2012-08-01 2016-07-19 Novozymes A/S Probiotic for amelioration of coccidiosis vaccine reaction
US10420783B2 (en) 2013-06-20 2019-09-24 Mars, Incorporated Performance food product
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
KR102358879B1 (ko) 2015-05-22 2022-02-08 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018187467A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (pd) and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CN113164527A (zh) 2018-09-27 2021-07-23 芬奇治疗控股有限责任公司 用于治疗癫痫和相关障碍的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953609A (en) * 1974-02-06 1976-04-27 Microlife Technics, Inc. Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
JPS54143585A (en) * 1978-04-28 1979-11-08 Kyowa Hakko Kogyo Co Ltd Culturing of microbials and storing of freeze-dried microbial cells
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4251509A (en) * 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration

Also Published As

Publication number Publication date
DK70385D0 (da) 1985-02-15
FI840816A0 (fi) 1984-03-01
CA1236400A (en) 1988-05-10
AU3758085A (en) 1985-09-05
ZA85324B (en) 1985-08-28
NO165744B (no) 1990-12-27
DK70385A (da) 1985-09-02
NO165744C (no) 1991-04-10
NO850817L (no) 1985-09-02
ES540375A0 (es) 1986-03-16
EP0154478A3 (en) 1987-06-10
EP0154478A2 (en) 1985-09-11
AU581198B2 (en) 1989-02-16
US4657762A (en) 1987-04-14
JPS60202823A (ja) 1985-10-14
JPH0759516B2 (ja) 1995-06-28

Similar Documents

Publication Publication Date Title
ES8605375A1 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
US4997657B1 (en) Method for improving skin smoothness.
HU9303150D0 (en) Combinated calcium and vitamin d complementaries
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
MY130047A (en) Methods and compositions employing certain lysozymes and endoglycosidases
MY101842A (en) Treatment of oral diseases.
FI860194A (fi) Lactobacillus acidophilus-kulturer.
ES2042868T3 (es) Un metodo de producir galidermina.
ES8602135A1 (es) Un procedimiento para la preparacion de un antibiotico bbm-2478.
ZA917767B (en) A nutritional composition and a process for its production
DE3268851D1 (en) Mixture for human supply of selenium as a trace substance
ES8606485A1 (es) Procedimiento para preparar una solucion antigenica libre decelulas
DE3367935D1 (en) Process for carrying out electromicrobial reductions
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
ES557404A0 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
DE3569075D1 (en) Method and compositions for use in the treatment of fireblight
MD909G2 (ro) Procedeu de obţinere a biomasei de alge roşii Porphyridium cruentum
GB9011347D0 (en) Production of a proteinaceous composition
GR3005736T3 (es)
EP0199085A3 (en) Jomol, its derivatives, process for the preparation of these substances, their use and their production
ES8608319A1 (es) Procedimiento para la produccion de un integrador alimenti- cio proteicovitaminico a partir de alga espirulina
AU7293387A (en) Process for the treatment of milk for cheesemaking
ES8706665A1 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
BG60542B2 (en) Water soluble composition having coccidiostatic effect
MX9701979A (es) Inhibicion de infeccion por rotavirus humano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051129